leisure time -WSS

leisure time

author：comprehensive 2025-09-03 12:03:32 - browse：8

NEW ORLEANS — For some patients suffering with certain blood cancers, CAR-T therapy can offer the tantalizing chance to end their disease with a single treatment.

But the immunotherapy takes time to manufacture, and patients often have to wait weeks to actually receive an infusion once they’re eligible. For some patients with especially aggressive cancer, they can die while waiting for the therapy to arrive.

That’s spurred CAR-T manufacturers to find ways to speed up manufacturing. The industry is testing newer — and possibly better — CAR-T cells that can be made more quickly. Researchers working with Novartis presented Phase 1 clinical trial data Sunday on a new CAR-T cell made with a rapid manufacturing process at the annual American Society of Hematology meeting.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： ‘The Bear’ and hospitality in hospitals

WSS

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

Some top drug companies are starting to take action on climate

Medicare innovation center doesn’t save money, experts say

Discs beat pads, tampons for heavy menstrual flow, new study shows

FTX founder Sam Bankman

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

explore

leisure time

focus

Heart attack and stroke risk calculators need revising

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

Duchenne breakthrough therapy leaves behind pioneering families

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

In Memoriam: Notable people who died in 2023

With Roe v Wade overturned, abortion providers work to adapt

United colonoscopy coverage change 'may cost lives,' doctors say

Wegovy cuts risk of cardiovascular events by 20%, study finds

New air purifier tech could be key to improving indoor air quality

Setback for rare diseases as Taysha Gene Therapies pulls back

entertainment

The painfully weak evidence on taking collagen to treat arthritis

Choosing scientific sides in the fight against Alzheimer's

What will Novo Nordisk's VC do with its influx of cash?

Study points to new risk in gene therapy death of Terry Horgan

Astronauts get first look at the spacecraft that will fly them around the moon

Travel bans should be based on evidence, not politics or fear

focus

focus

knowledge

hotspot